{"id":55291,"date":"2026-01-23T14:50:45","date_gmt":"2026-01-23T06:50:45","guid":{"rendered":"https:\/\/flcube.com\/?p=55291"},"modified":"2026-01-23T14:50:46","modified_gmt":"2026-01-23T06:50:46","slug":"bd-and-ypsomed-develop-neopak-xtraflow-5-5ml-prefilled-syringe-for-ypsomate-auto-injector","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55291","title":{"rendered":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector"},"content":{"rendered":"\n<p><strong>Becton, Dickinson and Co.<\/strong> (BD) and Swiss injection system developer <strong>Ypsomed<\/strong> announced an expanded collaboration to develop a <strong>5.5mL version of the BD Neopak XtraFlow glass prefilled syringe<\/strong>, designed for full compatibility with Ypsomed\u2019s <strong>YpsoMate 5.5 auto\u2011injector platform<\/strong>. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-collaboration-structure-amp-product-specifications\">Collaboration Structure &amp; Product Specifications<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>Becton, Dickinson and Co. (BD) \/ Ypsomed<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>BD Neopak XtraFlow 5.5mL glass prefilled syringe<\/td><\/tr><tr><td><strong>Platform Compatibility<\/strong><\/td><td>YpsoMate 5.5 auto\u2011injector<\/td><\/tr><tr><td><strong>Target Indication<\/strong><\/td><td>High\u2011volume subcutaneous self\u2011injection therapies<\/td><\/tr><tr><td><strong>Market Focus<\/strong><\/td><td>Pharmaceutical companies and patients<\/td><\/tr><tr><td><strong>Innovation<\/strong><\/td><td>First 5.5mL Neopak XtraFlow syringe optimized for auto\u2011injector integration<\/td><\/tr><tr><td><strong>Development Stage<\/strong><\/td><td>Co\u2011development phase; regulatory filing preparation underway<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile-amp-strategic-differentiation\">Technology Profile &amp; Strategic Differentiation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Neopak XtraFlow:<\/strong> BD\u2019s advanced glass prefilled syringe platform featuring ultra\u2011low tungsten residual, reduced particle generation, and enhanced break resistance<\/li>\n\n\n\n<li><strong>YpsoMate 5.5:<\/strong> Ypsomed\u2019s next\u2011generation auto\u2011injector designed for larger\u2011volume biologics (up to 5.5mL), supporting patient\u2011friendly self\u2011administration<\/li>\n\n\n\n<li><strong>Synergy:<\/strong> Combined solution addresses growing demand for <strong>high\u2011concentration, high\u2011volume biologics<\/strong> in immunology, oncology, and metabolic diseases<\/li>\n\n\n\n<li><strong>Patient Benefit:<\/strong> Enables less frequent dosing and improved adherence for chronic conditions requiring large\u2011volume injections<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-commercial-outlook\">Market Impact &amp; Commercial Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Subcutaneous Biologics Market:<\/strong> Global market valued at <strong>$120\u202fbillion<\/strong> in 2025, with high\u2011volume formulations growing at <strong>15% CAGR<\/strong><\/li>\n\n\n\n<li><strong>Competitive Advantage:<\/strong> Integrated BD\u2011Ypsomed solution reduces development risk for pharma clients by ensuring primary container and device compatibility from inception<\/li>\n\n\n\n<li><strong>Revenue Potential:<\/strong> Analysts estimate the 5.5mL prefilled syringe market will exceed <strong>$2\u202fbillion<\/strong> by 2030, driven by biosimilar and novel biologic launches<\/li>\n\n\n\n<li><strong>Strategic Fit:<\/strong> Expands BD\u2019s leadership in prefilled systems while strengthening Ypsomed\u2019s position in large\u2011volume auto\u2011injectors<\/li>\n\n\n\n<li><strong>Launch Timeline:<\/strong> Commercial availability targeted for <strong>2027<\/strong>, pending regulatory clearances<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief includes forward\u2011looking statements regarding development timelines, market projections, and commercial launch expectations for the Neopak XtraFlow 5.5mL syringe. Actual results may differ due to technical challenges, regulatory review outcomes, and competitive dynamics in the drug delivery market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2682],"class_list":["post-55291","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-becton-dickinson-and-company"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55291\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector\" \/>\n<meta property=\"og:description\" content=\"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55291\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-23T06:50:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T06:50:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector\",\"datePublished\":\"2026-01-23T06:50:45+00:00\",\"dateModified\":\"2026-01-23T06:50:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Becton Dickinson and Company\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55291#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55291\",\"name\":\"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-23T06:50:45+00:00\",\"dateModified\":\"2026-01-23T06:50:46+00:00\",\"description\":\"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55291\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55291#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector - Insight, China&#039;s Pharmaceutical Industry","description":"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55291","og_locale":"en_US","og_type":"article","og_title":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector","og_description":"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.","og_url":"https:\/\/flcube.com\/?p=55291","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-23T06:50:45+00:00","article_modified_time":"2026-01-23T06:50:46+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55291#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55291"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector","datePublished":"2026-01-23T06:50:45+00:00","dateModified":"2026-01-23T06:50:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55291"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Becton Dickinson and Company"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55291#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55291","url":"https:\/\/flcube.com\/?p=55291","name":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-23T06:50:45+00:00","dateModified":"2026-01-23T06:50:46+00:00","description":"Becton, Dickinson and Co. (BD) and Swiss injection system developer Ypsomed announced an expanded collaboration to develop a 5.5mL version of the BD Neopak XtraFlow glass prefilled syringe, designed for full compatibility with Ypsomed\u2019s YpsoMate 5.5 auto\u2011injector platform. The partnership aims to provide pharmaceutical companies and patients requiring high\u2011volume subcutaneous self\u2011injection with enhanced delivery options.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55291#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55291"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55291#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto\u2011Injector"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55291"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55291\/revisions"}],"predecessor-version":[{"id":55292,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55291\/revisions\/55292"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}